Publisher： John Wiley & Sons Inc
E-ISSN： 1440-1754|51|5|512-514
ISSN： 1034-4810
Source： JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol.51, Iss.5, 2015-05, pp. : 512-514
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
AbstractEosinophilic oesophagitis (EoE) is a key differential for gastro‐oesophageal reflux (GOR) in children. It can be difficult for clinicians to decide which patients need referral for the assessment of EoE, which can only be confirmed by histological analysis of endoscopic biopsies. Recent guidelines recommend that EoE can only be diagnosed following the exclusion of GOR through empiric treatment with proton pump inhibitors prior to endoscopy. Some aspects of history are strongly suggestive of EoE: red flags for referral include poor weight gain in the context of reflux symptoms, choking during eating or food impaction. Therapeutic options include dietary allergen elimination or swallowed aerosolised corticosteroids. Other novel therapies have failed to demonstrate benefit, but novel diagnostic biomarkers to enable non‐invasive disease ascertainment and follow‐up show some promise.
Related content
Access to resources
Recommend
